city New Delhi Usa 2020 city New Delhi Usa

Lupin gets EIR from USFDA for Nagpur plant

Reading now: 764
www.livemint.com

The US Food and Drug Administration (USFDA) issues an EIR to a company when an inspection is satisfactorily closed NEW DELHI : Drug maker Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant in Nagpur.

The US Food and Drug Administration (USFDA) issues an EIR to a company when an inspection is satisfactorily closed. The health regulator had inspected the the company's Nagpur manufacturing facility between January 6 and January 10, 2020, Lupin Ltd said in a statement. "We are very happy to have received the EIR for our Nagpur facility, our largest and most advanced oral solid dosage facility.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA